Chimeric advanced drug delivery nano systems (chi-aDDnSs) for shikonin combining dendritic and liposomal technology.
暂无分享,去创建一个
Costas Demetzos | K. Karatasos | C. Demetzos | K. Kontogiannopoulos | A. Assimopoulou | S. Hatziantoniou | V. Papageorgiou | Kostas Karatasos | Konstantinos N Kontogiannopoulos | Andreana N Assimopoulou | Sophia Hatziantoniou | Vassilios P Papageorgiou
[1] D. Begley,et al. Drug delivery and targeting to the CNS - Preface , 2002 .
[2] V. Samanidou,et al. Recent Advances in Chemistry, Biology and Biotechnology of Alkannins and Shikonins , 2006 .
[3] A. Assimopoulou,et al. Determination of naturally occurring hydroxynaphthoquinone polymers by size-exclusion chromatography , 2002 .
[4] R. Mülhaupt,et al. Hyperbranched polyesters and their application in dental composites: monomers for low shrinking composites , 2001 .
[5] A. Assimopoulou,et al. Study on isohexenylnaphthazarins polymerization in alkaline media. , 2004, Biomedical chromatography : BMC.
[6] Xin Chen,et al. Cellular pharmacology studies of shikonin derivatives , 2002, Phytotherapy research : PTR.
[7] K. Kono,et al. Synthesis of polyamidoamine dendrimers having poly(ethylene glycol) grafts and their ability to encapsulate anticancer drugs. , 2000, Bioconjugate chemistry.
[8] V. Papageorgiou. Naturally occurring isohexenylnaphthazarin pigments: a new class of drugs. , 1980, Planta medica.
[9] Brigitte Voit,et al. New developments in hyperbranched polymers , 2000 .
[10] C. Kiparissides,et al. Synthesis and release studies of shikonin-containing microcapsules prepared by the solvent evaporation method. , 2003, Journal of microencapsulation.
[11] Frank Caruso,et al. Effect of dendrimer on entrapment and release of bioactive from liposomes. , 2002, International journal of pharmaceutics.
[12] K. Nicolaou,et al. The Chemistry and Biology of Alkannin, Shikonin, and Related Naphthazarin Natural Products. , 1999, Angewandte Chemie.
[13] Costas Demetzos,et al. Type and location of interaction between hyperbranched polymers and liposomes. Relevance to design of a potentially advanced drug delivery nanosystem (aDDnS). , 2011, The journal of physical chemistry. B.
[14] K. Karatasos,et al. Association of a weakly acidic anti-inflammatory drug (ibuprofen) with a poly(amidoamine) dendrimer as studied by molecular dynamics simulations. , 2009, The journal of physical chemistry. B.
[15] 元英 林. 紫根および当帰の薬理学的研究(第2報) ―色素成分ShikoninならびにAcetylshikoninの薬理作用― , 1977 .
[16] P. Jansens,et al. Hyperbranched Polymers as Drug Carriers: Microencapsulation and Release Kinetics , 2006, Pharmaceutical development and technology.
[17] H. Cheng,et al. Photochemical decomposition of alkannin/shikonin enantiomers , 1995 .
[18] Sujatha Kannan,et al. Drug complexation, in vitro release and cellular entry of dendrimers and hyperbranched polymers. , 2003, International journal of pharmaceutics.
[19] D. Tomalia,et al. Poly(amidoamine) (PAMAM) dendrimers: from biomimicry to drug delivery and biomedical applications. , 2001, Drug discovery today.
[20] K. Dimas,et al. Shikonin‐loaded liposomes as a new drug delivery system: Physicochemical characterization and in vitro cytotoxicity , 2011 .
[21] K. Ahn,et al. Shikonin, acetylshikonin, and isobutyroylshikonin inhibit VEGF-induced angiogenesis and suppress tumor growth in lewis lung carcinoma-bearing mice. , 2008, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan.
[22] A. Assimopoulou,et al. Study on polymerization of the pharmaceutical substances isohexenylnaphthazarins. , 2004, Biomedical chromatography : BMC.
[23] Yun Zeng,et al. Inhibitory effect of acetylshikonin on human gastric carcinoma cell line SGC-7901 in vitro and in vivo. , 2009, World journal of gastroenterology.
[24] C. Panayiotou,et al. Electrospun fiber mats containing shikonin and derivatives with potential biomedical applications. , 2011, International journal of pharmaceutics.
[25] Y. Isomura,et al. Antitumor activity of shikonin and its derivatives. , 1977, Chemical & pharmaceutical bulletin.
[26] A. Assimopoulou,et al. Preparation and release studies of alkannin-containing microcapsules , 2004, Journal of microencapsulation.
[27] W. N.,et al. The Liposomal Formulation of Doxorubicin , 2005 .
[28] R. Schiffelers,et al. Liposomal nanomedicines as anticancer therapeutics: beyond targeting tumor cells. , 2008, International journal of pharmaceutics.
[29] P. Heegaard,et al. Dendrimers in drug research. , 2004, Chemical Society reviews.
[30] Robert Langer,et al. New frontiers in nanotechnology for cancer treatment. , 2008, Urologic oncology.
[31] Qun Zhou,et al. A novel antiestrogen agent Shikonin inhibits estrogen-dependent gene transcription in human breast cancer cells , 2010, Breast Cancer Research and Treatment.
[32] Di Chen,et al. Shikonin exerts antitumor activity via proteasome inhibition and cell death induction in vitro and in vivo , 2009, International journal of cancer.
[33] H. Stuppner,et al. Preparative isolation and purification of alkannin/shikonin derivatives from natural products by high-speed counter-current chromatography. , 2009, Biomedical chromatography : BMC.
[34] T Sakthivel,et al. Interaction of cationic partial dendrimers with charged and neutral liposomes. , 2001, International journal of pharmaceutics.
[35] Costas Demetzos,et al. Thermodynamic and structural characterization of Liposomal-Locked in-Dendrimers as drug carriers. , 2010, Colloids and surfaces. B, Biointerfaces.
[36] J. He. Complex of shikonin and β-cyclodextrins by using supercritical carbon dioxide , 2009 .
[37] K. Karatasos,et al. Local Dynamics and Hydrogen Bonding in Hyperbranched Aliphatic Polyesters , 2009 .
[38] K. Karatasos,et al. Modeling of hyperbranched polyesters as hosts for the multifunctional bioactive agent Shikonin. , 2011, Physical chemistry chemical physics : PCCP.
[39] K. Tsubono,et al. Biotransformation of shikonin by human intestinal bacteria , 1994 .
[40] A. Bangham,et al. Diffusion of univalent ions across the lamellae of swollen phospholipids. , 1965, Journal of molecular biology.
[41] A. Gabizon,et al. Sterically stabilized liposomes: improvements in pharmacokinetics and antitumor therapeutic efficacy. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[42] A. Assimopoulou,et al. Encapsulation of isohexenylnaphthazarins in cyclodextrins. , 2004, Biomedical chromatography : BMC.
[43] Narendra Kumar Jain,et al. Dendrimers in oncology: an expanding horizon. , 2009, Chemical reviews.
[44] B. R. Steele,et al. New drug delivery nanosystem combining liposomal and dendrimeric technology (liposomal locked-in dendrimers) for cancer therapy. , 2010, Journal of pharmaceutical sciences.
[45] Costas Demetzos,et al. New chimeric advanced Drug Delivery nano Systems (chi-aDDnSs) as doxorubicin carriers. , 2010, International journal of pharmaceutics.
[46] P. Oettgen,et al. Mechanism of inhibition of tumor angiogenesis by β‐hydroxyisovalerylshikonin , 2009, Cancer science.
[47] A. Assimopoulou,et al. Alkannins and shikonins: a new class of wound healing agents. , 2008, Current medicinal chemistry.
[48] Water-soluble degradable hyperbranched polyesters: novel candidates for drug delivery? , 2003, Biomacromolecules.
[49] R. Epand,et al. PAMAM dendrimers and model membranes: differential scanning calorimetry studies. , 2005, International journal of pharmaceutics.
[50] Costas Demetzos,et al. Doxorubicin-PAMAM dendrimer complex attached to liposomes: cytotoxic studies against human cancer cell lines. , 2005, International journal of pharmaceutics.
[51] William A. Goddard,et al. Starburst Dendrimers: Molecular‐Level Control of Size, Shape, Surface Chemistry, Topology, and Flexibility from Atoms to Macroscopic Matter , 1990 .
[52] Donald A Tomalia,et al. Dendrimers in biomedical applications--reflections on the field. , 2005, Advanced drug delivery reviews.
[53] É. Boisselier,et al. Dendrimers designed for functions: from physical, photophysical, and supramolecular properties to applications in sensing, catalysis, molecular electronics, photonics, and nanomedicine. , 2010, Chemical reviews.
[54] J. Fréchet,et al. Dendrimers and dendritic polymers in drug delivery. , 2005, Drug discovery today.